Bupivacaine HCl Inj. USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative Free Vial, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1162-02
Published March 12, 2014 · Recall initiated: February 10, 2014
Summary
FDA records drug Class II recall D-1147-2014, published March 12, 2014 and initiated February 10, 2014. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 115,500 Vials; Lot: Lot 25-097-DK; Exp 01/01/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Confirmed customer report of visible particulate embedded in the glass vial.
What to do
Voluntary: Firm initiated · Letter
Get an email if BUPIVACAINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BUPIVACAINE HYDROCHLORIDE
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide
- Lot
- Lot 25-097-DK; Exp 01/01/2015
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection, USP (15 mg/2 mL) (7.5 mg/mL) ampules, Rx only,April 22, 2026
- FDABupivacaine HCl Injection, single dose vial, Preservative Free 0.5%, 10mL (25/ct), Rx only, Manufacturer:June 15, 2022
- FDABupivacaine Hydrochloride, USP 0.5% (5mg/mL), 25 vials x 50 mL per box, Rx only, MFG: Pfizer, NDC 0409-1163-01June 15, 2022
- FDABupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials,December 28, 2016
- FDAa) Walgreens Lansoprazole Delayed Release Capsules, USP 15 mg/Acid Reducer, 14 capsules per Bottle, Dist byMarch 12, 2014
- FDAHeparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV or SC use, Multi-DoseMarch 12, 2014
Questions about this recall
Was Bupivacaine HCl Inj. USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative Free Vial, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1162-02 recalled?
Yes. FDA published recall D-1147-2014 on March 12, 2014. Reported hazard: Presence of Particulate Matter: Confirmed customer report of visible particulate embedded in the glass vial.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BUPIVACAINE HYDROCHLORIDE.